Yahoo
ASX - Delayed Quote AUD

Pharmx Technologies Limited (PHX.AX)

0.0700 -0.0020 (-2.78%)
At close: 4:10:15 PM GMT+11
Chart Range Bar
Loading chart for PHX.AX
  • Previous Close 0.0720
  • Open 0.0720
  • Bid 0.0690 x --
  • Ask 0.0730 x --
  • Day's Range 0.0700 - 0.0720
  • 52 Week Range 0.0640 - 0.1800
  • Volume 2,640,519
  • Avg. Volume 434,977
  • Market Cap (intraday) 46.803M
  • Beta (5Y Monthly) 0.35
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date Nov 28, 2023
  • 1y Target Est --

Pharmx Technologies Limited, together with its subsidiaries, engages in the technology and software development business in Australia and New Zealand. It offers Pharmx Gateway, an electronic ordering and invoicing solution; Pharmx Marketplace, an e-commerce ordering platform; and Pharmx Analytics, a solution that provides insights for suppliers and buyers. The company was formerly known as Corum Group Limited and changed its name to Pharmx Technologies Limited in October 2023. Pharmx Technologies Limited was incorporated in 1950 and is based in Sydney, Australia.

pharmx.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

PHX.AX
56.25%
S&P/ASX 200 [XJO] (^AXJO)
1.98%

1-Year Return

PHX.AX
54.84%
S&P/ASX 200 [XJO] (^AXJO)
0.83%

3-Year Return

PHX.AX
83.67%
S&P/ASX 200 [XJO] (^AXJO)
27.35%

5-Year Return

PHX.AX
7.34%
S&P/ASX 200 [XJO] (^AXJO)
19.64%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -23.97%

  • Return on Assets (ttm)

    -4.78%

  • Return on Equity (ttm)

    -9.31%

  • Revenue (ttm)

    7.62M

  • Net Income Avi to Common (ttm)

    -1.83M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.57M

  • Total Debt/Equity (mrq)

    2.32%

  • Levered Free Cash Flow (ttm)

    -2.28M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: